Itf Research Pharma, S.l.u.

Italfarmaco, Sa

Álvaro Acebrón Fernández

Jaime Moscoso Del Prado

Dolores Blanco Lousame

Concepción Nieto Magro

José Luis Pedraz Muñoz

Manuela Igatúa Olaechea

Alicia Rodriguez Gascón

Manuela Igartua Olaechea

Ana Campuzano Garcia

Rosa Maria Hernández Martin

Alicia Rodríguez Gascón

Cándida Gascó Guerrero

Ana Campuzano García

The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen-dependent tumor or suffering or having suffered from an estrogen-dependent tumor.

Treatment of vaginal atrophy in women with tumor pathology risk

The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology.

Treatment of vaginal atrophy in women with cardiovascular pathology risk

Semisolid mucoadhesive formulations for vaginal application, with improved technical and organoleptic characteristics, which contain at least two bioadhesive gelling polymers and an active ingredient, useful in the prevention and/or treatment of various pathologies and disorders in human beings or animals.

Semi-solid mucoadhesive formulations

The invention relates to the use of low doses of estriol by vaginal route for treatment and/or prevention of urogenital atrophy due to estrogen deficit in women.

Use of estriol in low doses

Growing community of inventors

Madrid, Spain

Álvaro Acebrón Fernández